Alterity Therapeutics Limited (ATHE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Alterity Therapeutics Lim...

NASDAQ: ATHE · Real-Time Price · USD
4.21
0.02 (0.48%)
At close: Oct 03, 2025, 3:59 PM
4.24
0.83%
After-hours: Oct 03, 2025, 04:10 PM EDT

Alterity Therapeutics Cash Flow Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-12.15M -19.12M -13.81M -12.85M -15.31M
Depreciation & Amortization
139.72K 147.53K 102.26K 54.21K 75.37K
Stock-Based Compensation
979.92K 881.95K 966.57K 1.51M 1.88M
Other Working Capital
-717.75K 23.05K -889.52K -393.29K -624.03K
Other Non-Cash Items
190.62K -261.15K -6.35M 455.57K -2.1M
Deferred Income Tax
n/a n/a 2.99M -1.06M 2.33M
Change in Working Capital
-613.68K 5.75M -3.94M -447.68K -4.22M
Operating Cash Flow
-11.45M -12.61M -20.04M -12.34M -17.33M
Capital Expenditures
n/a -5.72K -7.31K -89.15K -10.47K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
-7.5M n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -29.15K n/a n/a
Investing Cash Flow
-7.5M -5.72K -36.46K -89.15K -10.47K
Debt Repayment
-127.1K -10.37K -59.92K -34.51K -58.29K
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.77M -918.02K -132.41K -836.97K -2.49M
Financial Cash Flow
39.67M 9.22M 124.34K 16.3M 36.69M
Net Cash Flow
20.52M -3.13M -19.03M 6.69M 18.92M
Free Cash Flow
-11.45M -12.61M -20.04M -12.43M -17.34M